abington pharmacy limited Company Information
Company Number
05578101
Website
www.cedarroaddental.co.ukRegistered Address
17 david road, colnbrook, slough, berkshire, SL3 0DB
Industry
Dispensing chemist in specialised stores
Telephone
01604720010
Next Accounts Due
March 2025
Group Structure
View All
Shareholders
pill box chemists limited 100%
abington pharmacy limited Estimated Valuation
Pomanda estimates the enterprise value of ABINGTON PHARMACY LIMITED at £398.5k based on a Turnover of £1.4m and 0.29x industry multiple (adjusted for size and gross margin).
abington pharmacy limited Estimated Valuation
Pomanda estimates the enterprise value of ABINGTON PHARMACY LIMITED at £508.6k based on an EBITDA of £110.4k and a 4.61x industry multiple (adjusted for size and gross margin).
abington pharmacy limited Estimated Valuation
Pomanda estimates the enterprise value of ABINGTON PHARMACY LIMITED at £0 based on Net Assets of £-105.8k and 2.46x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Abington Pharmacy Limited Overview
Abington Pharmacy Limited is a live company located in slough, SL3 0DB with a Companies House number of 05578101. It operates in the dispensing chemist in specialised stores sector, SIC Code 47730. Founded in September 2005, it's largest shareholder is pill box chemists limited with a 100% stake. Abington Pharmacy Limited is a established, small sized company, Pomanda has estimated its turnover at £1.4m with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Abington Pharmacy Limited Health Check
Pomanda's financial health check has awarded Abington Pharmacy Limited a 1.5 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 8 areas for improvement. Company Health Check FAQs
1 Strong
3 Regular
8 Weak
Size
annual sales of £1.4m, make it smaller than the average company (£12m)
- Abington Pharmacy Limited
£12m - Industry AVG
Growth
3 year (CAGR) sales growth of -16%, show it is growing at a slower rate (5.4%)
- Abington Pharmacy Limited
5.4% - Industry AVG
Production
with a gross margin of 31.3%, this company has a comparable cost of product (31.3%)
- Abington Pharmacy Limited
31.3% - Industry AVG
Profitability
an operating margin of 2.7% make it as profitable than the average company (2.4%)
- Abington Pharmacy Limited
2.4% - Industry AVG
Employees
with 25 employees, this is below the industry average (85)
25 - Abington Pharmacy Limited
85 - Industry AVG
Pay Structure
on an average salary of £22.8k, the company has an equivalent pay structure (£22.8k)
- Abington Pharmacy Limited
£22.8k - Industry AVG
Efficiency
resulting in sales per employee of £54.9k, this is less efficient (£129k)
- Abington Pharmacy Limited
£129k - Industry AVG
Debtor Days
it gets paid by customers after 1 days, this is earlier than average (31 days)
- Abington Pharmacy Limited
31 days - Industry AVG
Creditor Days
its suppliers are paid after 22 days, this is quicker than average (67 days)
- Abington Pharmacy Limited
67 days - Industry AVG
Stock Days
it holds stock equivalent to 92 days, this is more than average (31 days)
- Abington Pharmacy Limited
31 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 5 weeks, this is less cash available to meet short term requirements (16 weeks)
5 weeks - Abington Pharmacy Limited
16 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 114.7%, this is a higher level of debt than the average (59.4%)
114.7% - Abington Pharmacy Limited
59.4% - Industry AVG
ABINGTON PHARMACY LIMITED financials
Abington Pharmacy Limited's latest turnover from June 2023 is estimated at £1.4 million and the company has net assets of -£105.8 thousand. According to their latest financial statements, Abington Pharmacy Limited has 25 employees and maintains cash reserves of £78 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | ||||||||||||||
Other Income Or Grants | ||||||||||||||
Cost Of Sales | ||||||||||||||
Gross Profit | ||||||||||||||
Admin Expenses | ||||||||||||||
Operating Profit | ||||||||||||||
Interest Payable | ||||||||||||||
Interest Receivable | ||||||||||||||
Pre-Tax Profit | ||||||||||||||
Tax | ||||||||||||||
Profit After Tax | ||||||||||||||
Dividends Paid | ||||||||||||||
Retained Profit | ||||||||||||||
Employee Costs | ||||||||||||||
Number Of Employees | 25 | 26 | 26 | 31 | 34 | 34 | 32 | 33 | ||||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 15,061 | 18,827 | 23,534 | 21,555 | 6,470 | 26,059 | 39,320 | 52,924 | 36,217 | 67,955 | 102,530 | 136,348 | 171,681 | 184,791 |
Intangible Assets | 260,792 | 330,338 | 399,884 | 469,430 | 538,976 | 625,908 | 695,454 | 765,000 | 834,546 | 904,092 | 973,638 | 1,043,184 | 1,112,730 | 1,182,276 |
Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 275,853 | 349,165 | 423,418 | 490,985 | 545,446 | 651,967 | 734,774 | 817,924 | 870,763 | 972,047 | 1,076,168 | 1,179,532 | 1,284,411 | 1,367,067 |
Stock & work in progress | 238,380 | 245,460 | 93,290 | 95,610 | 96,517 | 74,061 | 75,163 | 80,145 | 64,826 | 74,511 | 60,707 | 65,892 | 66,342 | 54,449 |
Trade Debtors | 4,086 | 114,845 | 292,420 | 281,990 | 276,483 | 280,442 | 296,857 | 321,464 | 374,079 | 355,221 | 383,604 | 411,869 | 403,099 | 409,662 |
Group Debtors | 32,250 | 32,250 | 33,000 | 136,019 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Misc Debtors | 91,924 | 23,005 | 34,031 | 24,505 | 24,862 | 23,143 | 24,194 | 25,678 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash | 78,025 | 182,850 | 64,688 | 72,861 | 6,273 | 10,209 | 20,968 | 30,952 | 10,630 | 57,275 | 6,252 | 23,385 | 50,384 | 8,271 |
misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current assets | 444,665 | 598,410 | 517,429 | 610,985 | 404,135 | 387,855 | 417,182 | 458,239 | 449,535 | 487,007 | 450,563 | 501,146 | 519,825 | 472,382 |
total assets | 720,518 | 947,575 | 940,847 | 1,101,970 | 949,581 | 1,039,822 | 1,151,956 | 1,276,163 | 1,320,298 | 1,459,054 | 1,526,731 | 1,680,678 | 1,804,236 | 1,839,449 |
Bank overdraft | 48,920 | 49,303 | 49,345 | 24,858 | 42,313 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 58,755 | 361,799 | 331,280 | 345,816 | 326,193 | 275,834 | 277,176 | 302,041 | 474,274 | 548,577 | 537,547 | 536,444 | 554,389 | 612,567 |
Group/Directors Accounts | 143,698 | 82,478 | 47,391 | 0 | 423,710 | 22,802 | 20,604 | 40,017 | 0 | 0 | 0 | 0 | 0 | 0 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 556,772 | 564,002 | 543,179 | 728,046 | 122,050 | 44,809 | 36,208 | 41,071 | 0 | 0 | 0 | 0 | 0 | 0 |
total current liabilities | 808,145 | 1,057,582 | 971,195 | 1,098,720 | 914,266 | 343,445 | 333,988 | 383,129 | 474,274 | 548,577 | 537,547 | 536,444 | 554,389 | 612,567 |
loans | 18,185 | 22,787 | 25,000 | 25,000 | 0 | 400,000 | 450,000 | 500,000 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 0 | 0 | 0 | 0 | 0 | 113,000 | 113,000 | 113,000 | 583,000 | 599,821 | 672,249 | 794,677 | 917,105 | 933,000 |
provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total long term liabilities | 18,185 | 22,787 | 25,000 | 25,000 | 0 | 513,000 | 563,000 | 613,000 | 583,000 | 599,821 | 672,249 | 794,677 | 917,105 | 933,000 |
total liabilities | 826,330 | 1,080,369 | 996,195 | 1,123,720 | 914,266 | 856,445 | 896,988 | 996,129 | 1,057,274 | 1,148,398 | 1,209,796 | 1,331,121 | 1,471,494 | 1,545,567 |
net assets | -105,812 | -132,794 | -55,348 | -21,750 | 35,315 | 183,377 | 254,968 | 280,034 | 263,024 | 310,656 | 316,935 | 349,557 | 332,742 | 293,882 |
total shareholders funds | -105,812 | -132,794 | -55,348 | -21,750 | 35,315 | 183,377 | 254,968 | 280,034 | 263,024 | 310,656 | 316,935 | 349,557 | 332,742 | 293,882 |
Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | ||||||||||||||
Operating Profit | ||||||||||||||
Depreciation | 3,766 | 4,707 | 4,695 | 12,502 | 19,748 | 13,261 | 13,604 | 13,602 | 33,320 | 34,825 | 35,530 | 35,333 | 40,690 | 12,462 |
Amortisation | 69,546 | 69,546 | 69,546 | 69,546 | 86,932 | 69,546 | 69,546 | 69,546 | 69,546 | 69,546 | 69,546 | 69,546 | 69,546 | 69,546 |
Tax | ||||||||||||||
Stock | -7,080 | 152,170 | -2,320 | -907 | 22,456 | -1,102 | -4,982 | 15,319 | -9,685 | 13,804 | -5,185 | -450 | 11,893 | 54,449 |
Debtors | -41,840 | -189,351 | -83,063 | 141,169 | -2,240 | -17,466 | -26,091 | -26,937 | 18,858 | -28,383 | -28,265 | 8,770 | -6,563 | 409,662 |
Creditors | -303,044 | 30,519 | -14,536 | 19,623 | 50,359 | -1,342 | -24,865 | -172,233 | -74,303 | 11,030 | 1,103 | -17,945 | -58,178 | 612,567 |
Accruals and Deferred Income | -7,230 | 20,823 | -184,867 | 605,996 | 77,241 | 8,601 | -4,863 | 41,071 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash flow from operations | ||||||||||||||
Investing Activities | ||||||||||||||
capital expenditure | ||||||||||||||
Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
cash flow from investments | ||||||||||||||
Financing Activities | ||||||||||||||
Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 61,220 | 35,087 | 47,391 | -423,710 | 400,908 | 2,198 | -19,413 | 40,017 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | -4,602 | -2,213 | 0 | 25,000 | -400,000 | -50,000 | -50,000 | 500,000 | 0 | 0 | 0 | 0 | 0 | 0 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 | 0 | -113,000 | 0 | 0 | -470,000 | -16,821 | -72,428 | -122,428 | -122,428 | -15,895 | 933,000 |
share issue | ||||||||||||||
interest | ||||||||||||||
cash flow from financing | ||||||||||||||
cash and cash equivalents | ||||||||||||||
cash | -104,825 | 118,162 | -8,173 | 66,588 | -3,936 | -10,759 | -9,984 | 20,322 | -46,645 | 51,023 | -17,133 | -26,999 | 42,113 | 8,271 |
overdraft | -383 | -42 | 24,487 | -17,455 | 42,313 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | -104,442 | 118,204 | -32,660 | 84,043 | -46,249 | -10,759 | -9,984 | 20,322 | -46,645 | 51,023 | -17,133 | -26,999 | 42,113 | 8,271 |
abington pharmacy limited Credit Report and Business Information
Abington Pharmacy Limited Competitor Analysis
Perform a competitor analysis for abington pharmacy limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other small companies, companies in SL3 area or any other competitors across 12 key performance metrics.
abington pharmacy limited Ownership
ABINGTON PHARMACY LIMITED group structure
Abington Pharmacy Limited has no subsidiary companies.
abington pharmacy limited directors
Abington Pharmacy Limited currently has 2 directors. The longest serving directors include Mrs Harminder Virdee (Jul 2019) and Mr Davinder Virdee (Jul 2019).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mrs Harminder Virdee | England | 59 years | Jul 2019 | - | Director |
Mr Davinder Virdee | England | 59 years | Jul 2019 | - | Director |
P&L
June 2023turnover
1.4m
-34%
operating profit
37.1k
0%
gross margin
31.4%
-3.88%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
June 2023net assets
-105.8k
-0.2%
total assets
720.5k
-0.24%
cash
78k
-0.57%
net assets
Total assets minus all liabilities
abington pharmacy limited company details
company number
05578101
Type
Private limited with Share Capital
industry
47730 - Dispensing chemist in specialised stores
incorporation date
September 2005
age
19
incorporated
UK
ultimate parent company
accounts
Small Company
last accounts submitted
June 2023
previous names
N/A
accountant
MUS ACCOUNTANTS LIMITED
auditor
-
address
17 david road, colnbrook, slough, berkshire, SL3 0DB
Bank
-
Legal Advisor
-
abington pharmacy limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 4 charges/mortgages relating to abington pharmacy limited. Currently there are 3 open charges and 1 have been satisfied in the past.
abington pharmacy limited Companies House Filings - See Documents
date | description | view/download |
---|